EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multimodal CT and MRI Radiomics Integrated with Clinical Models Predict Pathological Complete Response in ESCC Following Neoadjuvant Immunochemotherapy

Longgao Liu, Chufeng Zeng, Lizhi Liu, Shumin Zhou, Weihua Wu, Peng Lin, Jianhua Fu, Tiehua Rong, Xu Zhang, Xiaodong Su

Tomography · 19.11.2025 · 11 (11) · 130

DOI: 10.3390/tomography11110130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tomography, online erschienen am 19.11.2025. Verfasst von Longgao Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou 510060, China. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Esophageal Neoplasms, Tomography, X-Ray Computed, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Guangdong Esophageal Cancer Institute, Youth Project, Guangdong Esophageal Cancer Institute Youth Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This research focused on evaluating the utility of multimodal radiomics integrated with machine learning to predict pathological complete response (pCR) in a prospective cohort of esophageal squamous cell carcinoma (ESCC) patients undergoing neoadjuvant immunochemotherapy (nICT).

Methods

We retrospectively analyzed prospectively collected trial data from 66 ESCC patients. Radiomic features were extracted from computed tomography (CT) and magnetic resonance imaging (MRI) images. Four machine learning algorithms—Random Forest (RF), logistic regression, Support Vector Machine, and Extreme Gradient Boosting (XGBoost)—were applied with leave-one-out cross-validation to predict pCR after nICT. The predictive performance of the models was evaluated using receiver operating characteristic curve analysis.

Results

In total, 851 features were identified. Among the four machine learning algorithms, the XGBoost machine learning method demonstrated the best model performance across CT, MRI, and clinical feature-based models. Furthermore, the integrated model demonstrated superior performance compared to individual models based solely on CT, MRI, or clinical features across all machine learning algorithms. Among these, the XGboost-based integrated model achieved the highest performance on the test set, with an AUC of 0.961, a TPR of 84.2%, a TNR of 95.7%, a PPV 88.9% of and a NPV of 93.8%. Decision curve analysis validated the model’s robust clinical utility, with calibration curves demonstrating strong concordance between predicted and observed therapeutic responses.

Conclusions

The study demonstrates the potential for predicting pCR in patients with ESCC treated with standardized neoadjuvant chemotherapy and PD-1 inhibitors using machine learning methods that integrate multimodal CT and MRI images with clinical features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingEsophageal NeoplasmsTomography, X-Ray ComputedEsophageal Squamous Cell CarcinomaMultimodal ImagingHumansNeoadjuvant TherapyMaleFemaleMiddle AgedRetrospective StudiesMachine LearningAgedTreatment OutcomeProspective StudiesPredictive Value of TestsAdultImmunotherapyRadiomics

Stichwörter der Autor:innen

esophageal squamous cell carcinomamultimodalneoadjuvant immunochemotherapypathological complete responseradiomics

Autor:innen und Institutionen

  • Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou 510060, China.
  • Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China.
  • Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China.

Förderung

  • the Guangdong Esophageal Cancer Institute, Youth Project
  • Guangdong Esophageal Cancer Institute Youth Project

Zitieren

APA

Liu, L., Zeng, C., Liu, L., Zhou, S., Wu, W., Lin, P., Fu, J., Rong, T., Zhang, X., & Su, X. (2025). Multimodal CT and MRI Radiomics Integrated with Clinical Models Predict Pathological Complete Response in ESCC Following Neoadjuvant Immunochemotherapy. Tomography, 11(11), 130. https://doi.org/10.3390/tomography11110130

Vancouver

Liu L, Zeng C, Liu L, Zhou S, Wu W, Lin P, et al. Multimodal CT and MRI Radiomics Integrated with Clinical Models Predict Pathological Complete Response in ESCC Following Neoadjuvant Immunochemotherapy. Tomography. 2025;11(11):130. doi:10.3390/tomography11110130

BibTeX
@article{Liu2025,
  author = {Liu, Longgao and Zeng, Chufeng and Liu, Lizhi and Zhou, Shumin and Wu, Weihua and Lin, Peng and Fu, Jianhua and Rong, Tiehua and Zhang, Xu and Su, Xiaodong},
  title = {Multimodal CT and MRI Radiomics Integrated with Clinical Models Predict Pathological Complete Response in ESCC Following Neoadjuvant Immunochemotherapy},
  journal = {Tomography},
  year = {2025},
  volume = {11},
  number = {11},
  pages = {130},
  doi = {10.3390/tomography11110130}
}
Kostenlos starten →